3 min

COVID-19: INRAE supports clinical research and hospitals

On Friday 20 March, INRAE launched an inventory of the human and material resources which it could put at the disposal of healthcare institutions and personnel. This inventory is being carried out under the supervision of the Presidents of INRAE’s research centres throughout France. More than 71,000 masks including 26,000 FFP2 & FFP3 masks, more than 2,300 litres of hydroalcoholic solution or equivalent, as well as glasses, head covers, gloves, shoe covers, disposable gowns and overalls have been collected. This initiative strengthens and coordinates local initiatives already in place and helps them meet the requests and requirements of the university hospitals and regional health agencies. At the request of the Ministry of Higher Education, Research and Innovation, the initiative is conducted in coordination with our 4 partners: CNRS, INSERM, CEA, INRIA.

Published on 23 March 2020

illustration COVID-19: INRAE supports clinical research and hospitals

All INRAE news on COVID-19

Extract of Philippe Mauguin’s message to the Presidents of INRAE centres, Division Heads and Unit Directors on Friday 20 March:


"Many of you are contacting us to offer the human and material resources of your laboratories and units in order to help prevent, detect and treat in the present crisis. These are generous offers and we would like to thank you, and our colleagues who have volunteered, very warmly.  

For obvious reasons of efficiency, we must make a list of these offers so that they correspond to requests. This procedure has been validated during the daily meeting between the main French research organisations and the Ministry of Higher Education, Research and Innovation (MESRI). The MESRI is in charge of relations with the Ministry for Solidarity and Health which will deal in particular with the sensitive questions related to organizing diagnoses and care.

We draw to your attention that the services which we will offer must not call into question the most important research or clinical trials which we are conducting on COVID-19 or other subjects for which we have decided to continue our activities. They must be conducted under safe conditions and deliver reliable and exploitable results.  

If you are concerned by these subjects, we ask you to convey the information below to colleagues in your unit then inform the President of your Centre. The President of your Centre will contact the university hospital or the reference hospital in proximity which will specify its requirements to us.

This procedure will be carried out in close consultation between the CEA, CNRS, INRAE, INRIA and INSERM who are sending out a similar message to their units and regional delegates. We will also inform our university partners of this initiative. If your laboratory depends on several institutes, you should relay the information to one of them, and notify the others.

 Procedure in the research units:

On the proposal of the head of laboratory/unit, an inventory of the following is made:

  • The stocks of protective masks, gloves and glasses, reagents (particularly for PCR), apart from those necessary for the laboratory’s own needs, can be made available to the university hospital or reference hospital in proximity.
  • Machines, particularly PCR type machines, available in your lab can be made available to the university hospital or reference hospital in proximity.
  • The human resources which can be mobilised in laboratories will be requested in an organised manner, strictly on a volunteer basis, to meet two needs in priority:

1) the continuity of clinical research protocols conducted with the support of Clinical Investigation Centres (the hospital staff of these structures being increasingly required for emergency care)

2) the increase of hospital diagnoses using PCR. A call for expertise will shortly be launched to meet the first needs identified.

The business continuity plans of the unit will be updated to include these activities which were not able to be identified initially.

The Presidents of the Centres will then collect

- The aggregated list of the small equipment and reagents made available to the university hospital or reference hospital in proximity.

- The list of machines made available to the university hospital or reference hospital in proximity”


[#JeVeuxAider] The French government is calling for volunteers to help with emergency & food aid, childcare and help for isolated and/or vulnerable people

covid-19 Missions réserve civique carré covid-19 Jeveuxaider Renforts

Direction générale INRAE

Learn more

Food, Global Health

Dealing with emerging diseases: rethinking how we monitor global health

PRESS RELEASE - Is disease X already here? Does the arrival of COVID-19 mean we need to rethink our health monitoring systems? As part of the MOOD project, which began in January 2020, European and North American researchers are doing just that by looking at how we might detect early signs of new epidemics. As an expert in such emerging diseases, most of which come from animals, CIRAD is coordinating this project that brings together 25 research institutes and public health agencies.

19 March 2020

Coronavirus: INRAE’s crisis plan for the COVID-19 epidemic is being implemented

Like all institutions, INRAE is organising itself to face the progression of the coronavirus COVID-19 epidemic. A crisis unit set up several days ago is ensuring the Institute’s continuity of service. Regular information is provided to staff. Recommendations related to social distancing, with telecommuting becoming generalized whenever possible, are implemented in all our centres for all activities which are not essential.

19 March 2020


Disorder is adaptive for viruses

Certain plant viruses encode "disordered" proteins, whose structural flexibility can more easily accommodate mutations. These proteins may increase virus adaptability and, in particular, allow viruses to evade genetically enhanced crop resistance. This advantage has been experimentally demonstrated for the first time by infecting resistant pepper plants with high-disorder Potato virus Y mutants.

20 March 2020